Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey

European Journal of Preventive Cardiology

Volumn 24, Issue 6, 2017, Pages 567-576

  Griffo, Raffaele ^a   Spanevello, Antonio ^b   Temporelli, Pier Luigi ^c   Faggiano, Pompilio ^d   Carone, Mauro ^c   Magni, Giovanna ^e   Ambrosino, Nicolino ^f   Tavazzi, Luigi ^g  

^a Italian Association for Cardiovascular Prevention and Rehabilitation   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c IRCCS   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e QBGroup SpA   (Italy)

^f Cardio Pulmonary Rehab Department Auxilium Vitae   (Italy)

^g MARIA CECILIA HOSPITAL   (Italy)

Author keywords

Cardiopulmonary rehabilitation; Chronic heart failure; Chronic obstructive pulmonary disease; Epidemiology; Observational research; Survey

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGED; ANEMIA; ATRIAL FIBRILLATION; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSPNEA; FATIGUE; FEMALE; FLUID RETENTION; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; OBSERVATIONAL STUDY; PHYSICAL INACTIVITY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SIX MINUTE WALK TEST; SPUTUM ANALYSIS; CHRONIC DISEASE; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; HEALTH STATUS; HEALTH SURVEY; ITALY; LIFESTYLE; MIDDLE AGED; OUTPATIENT; PATHOPHYSIOLOGY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HEART FAILURE; HUMANS; ITALY; LIFE STYLE; MALE; MIDDLE AGED; OUTPATIENTS; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 85018675700     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487316687425     Document Type: Review

References (30)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012; 380: 2095-2128.
2. Mannino DM and Buist AS. Global burden of COPD: risk factors, prevalence and future trends. Lancet 2007; 370: 765-773.
3. Lange PM, Marott JL, Vestbo J, et al. Prediction of the clinical course of COPD using the new GOLD classification. A study of the general population. Am J Respir Crit Care Med 2012; 186: 975-981.
4. Lykkegard J, Sondergaard J, Kragstrup J, et al. All Danish first-time COPD hospitalization 2002-2008: incidence, outcome, patients and care. Respir Med 2012; 106: 549-556.
5. McCullough PA, Philbin EF, Spertus JA, et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002; 1: 60-69.
6. Ezekowitz JA, Kaul P, Bakal JA, et al. Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics? Eur J Heart Fail 2011; 13: 142-147.
7. Jhund PS, MacIntyre K, Simpson CR, et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: A population study of 5.1 million people. Circulation 2009; 119: 515-523.
8. Ferreira EV, Ota-Arakaki JS, Ramos RP, et al. Optimizing the evaluation of excess exercise ventilation for prognosis assessment in pulmonary arterial hypertension. Eur J Prev Cardiol 2014; 21: 1409-1419.
9. Barron A, Dhutia N, Mayet J, et al. Test-retest repeatability of cardiopulmonary exercise test variables in patient with cardiac or respiratory disease. Eur J Prev Cardiol 2014; 21: 445-453.
10. Ukena C, Mahfoud F, Kindermann M, et al. The cardiopulmonary continuum systemic inflammation as "common soli" of heart and lung disease. Int J Cardiol 2010; 145: 172-176.
11. Libby P, Ridker PM and Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
12. Magini A, Apostolo A, Salvioni E, et al. Alveolar-capillary membrane diffusion measurement by nitric oxide inhalation in heart failure. Eur J Prev Cardiol 2015; 22: 206-212.
13. Tavazzi L, Swedberg K, Komajda M, et al.; on behalf of the SHIFT Investigators. Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study. Intern J Cardiol 2013; 170: 182-188.
14. Mentz RJ, Fiuzat M, Wojdyla DM, et al. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF. Eur J Heart Fail 2012; 14: 395-403.
15. Mentz RJ, Schmidt PH, Kwasny MJ, et al. The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial. J Card Fail 2012; 18: 515-523.
16. Mentz RJ, Schulte PJ, Fleg JL, et al. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION). Am Heart J 2013; 165: 193-199.
17. Hawkins NM, Virani S and Ceconi C. Heart failure and COPD: The challenges facing physicians and health services. Eur Heart J 2013; 34: 2795-2803.
18. Boudestein LC, Rutten FH and Cramer MJ. The impact of concurrent heart failure on prognosis in patients with COPD. Eur J Heart Fail 2009; 11: 1182-1188.
19. Griffo R, Spanevello A, Temporelli PL, et al. Italian survey on prevalence and disease management of chronic heart failure and chronic obstructive pulmonary disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design. Monaldi Arch Chest Dis 2014; 82: 29-34.
20. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. Updated 2013. 2013 Global Initiative for Chronic Obstructive Lung Disease Inc. wwwgoldcopd.org. (accessed 15 March 2013).
21. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-1847.
22. Apostolovic S, Jancovic-Tomasevic R, Salinger-Martinovic S, et al. Frequency and significance of unrecognized chronic obstructive pulmonary disease in elderly patients with stable heart disease. Aging Clin Exp Res 2011; 23: 337-342.
23. Steinacher R, Parissis JT, Strohmer B, et al. Comparison between ATS/ERS age and gender adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure. Clin Res Cardiol 2012; 101: 637-645.
24. Boschetto P, Fucili A, Stendardo M, et al. Occurrence and impact of COPD in elderly patients with stable heart failure. Respirology 2013; 18: 125-130.
25. Minasian AG, van den Elshout FJ, Dekhuijzen PN, et al. COPD in chronic heart failure: less common than previously thought? Heart Lung 2013; 42: 365-371.
26. Beghé B, Verduri A, Bottazzi B, et al. Echocardiography, spirometry, and systemic acute-phase inflammatory proteins in smokers with COPD or CHF: an observational study. PLOS One 2013; 8: e80166. doi:10.1371/journal.pone.0080166.
27. Macchia A, Rodriguez Moncalvo JJ, Kleinert M, et al. Unrecognised ventricular dysfunction in COPD. Eur Respir J 2012; 39: 51-58.
28. Finkelstein J, Cha E and Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis 2009; 4: 337-349.
29. Curkendall SM, Lanes S, de Luise C, et al. Chronic obstructive pulmonary disease severity and cardiovascular outcomes. Eur J Epidemiol 2006; 21: 803-813.
30. Rutten FH, Cramer MJ, Grobbee DE, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005; 26: 1887-1894.